Veru (VERU) Dividends Paid - Common Growth (1y) (2011 - 2015)
Veru (VERU) Dividends Paid - Common Growth (1y) (2011 - 2015) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -10.39% |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -99.99% |
| Dec 31, 2014 | -99.74% |
| Sep 30, 2014 | -101.96% |
| Jun 30, 2014 | 7.13% |
| Dec 31, 2013 | 17.65% |
| Sep 30, 2013 | 18.94% |
| Jun 30, 2013 | -30.16% |
| Mar 31, 2013 | 567.22% |
| Dec 31, 2012 | 21.00% |
| Sep 30, 2012 | 23.64% |
| Jun 30, 2012 | -32.47% |
| Dec 31, 2011 | 93,565.27% |
| Sep 30, 2011 | 133.45% |